Table 2 Disability weights with uncertainty intervals (UI) for 206 health states in Wuhan

Infectious disease

1

 Acute episode, mild

0.012 (0.001–0.054)

2

 Acute episode, moderate

0.087 (0.022–0.202)

3

 Acute episode, severe

0.11 (0.034–0.228)

4

 Post-acute consequences (fatigue, emotional lability, and insomnia)

0.065 (0.013–0.169)

Diarrhoea

5

 Mild

0.057 (0.011–0.152)

6

 Moderate

0.148 (0.059–0.266)

7

 Severe

0.238 (0.126–0.352)

8

Epididymo-orchitis

0.085 (0.022–0.197)

9

Herpes zoster

0.022 (0.002–0.083)

10

HIV: symptomatic, pre-AIDS

0.15 (0.059–0.271)

11

HIV/AIDS: receiving antiretroviral (ARV) treatment

0.049 (0.008–0.138)

12

AIDS: not receiving antiretroviral (ARV) treatment

0.392 (0.272–0.5)

13

Intestinal nematode infections: symptomatic

0.059 (0.012–0.164)

14

Lymphatic filariasis: symptomatic

0.154 (0.059–0.272)

15

Ear pain

0.032 (0.004–0.109)

Tuberculosis

16

 Not HIV infected

0.292 (0.177–0.404)

17

 HIV infected

0.39 (0.272–0.496)

Cancer

18

 Diagnosis and primary treatment

0.166 (0.07–0.29)

19

 Metastatic

0.29 (0.168–0.394)

Terminal phase

20

 With medication (for cancers and end-stage kidney or liver disease)

0.568 (0.462–0.69)

21

 Without medication (for cancers and end-stage kidney or liver disease)

0.344 (0.223–0.445)

Cardiovascular and circulatory disease

 Acute myocardial infarction

22

  Days 1–2

0.303 (0.185–0.407)

23

  Days 3–28

0.068 (0.015–0.172)

Angina pectoris

24

 Mild

0.032 (0.004–0.108)

25

 Moderate

0.051 (0.009–0.144)

26

 Severe

0.154 (0.064–0.27)

27

Cardiac conduction disorders and cardiac dysrhythmias

0.174 (0.074–0.293)

28

Claudication

0.016 (0.001–0.067)

Heart failure

29

 Mild

0.052 (0.009–0.148)

30

 Moderate

0.069 (0.014–0.175)

31

 Severe

0.146 (0.055–0.271)

Stroke

32

 Long-term consequences, mild

0.028 (0.003–0.098)

33

 Long-term consequences, moderate

0.042 (0.006–0.123)

34

 Long-term consequences, moderate plus cognition problems

0.097 (0.028–0.213)

35

 Long-term consequences, severe

0.272 (0.153–0.377)

36

 Long-term consequences, severe plus cognition problems

0.288 (0.172–0.402)

Diabetes and digestive and genitourinary disease

37

 Diabetic neuropathy

0.081 (0.019–0.189)

38

 Chronic kidney disease (stage IV)

0.049 (0.009–0.144)

 End-stage renal disease

39

  With kidney transplantation

0.043 (0.007–0.128)

40

  On dialysis

0.571 (0.459–0.694)

41

 Decompensated cirrhosis of the liver

0.072 (0.016–0.178)

42

 Gastric bleeding

0.21 (0.099–0.327)

43

 Crohn’s disease or ulcerative colitis

0.136 (0.05–0.26)

44

 Benign prostatic hypertrophy: symptomatic

0.05 (0.009–0.141)

45

 Urinary incontinence

0.17 (0.074–0.282)

46

 Stress incontinence

0.022 (0.002–0.084)

47

 Impotence

0.016 (0.001–0.065)

 Infertility

48

  Primary

0.013 (0.001–0.059)

49

  Secondary

0.011 (0.001–0.053)

50

 Heart burn & reflux “GERD”

0.062 (0.012–0.162)

Chronic respiratory disease

 Asthma

51

  Controlled

0.022 (0.002–0.084)

52

  Partially controlled

0.045 (0.007–0.128)

53

  Uncontrolled

0.221 (0.105–0.34)

 Chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases

54

  Mild

0.017 (0.001–0.069)

55

  Moderate

0.175 (0.074–0.294)

56

  Severe

0.265 (0.142–0.379)

Neurological disorders

 Dementia

57

  Mild

0.027 (0.003–0.096)

58

  Moderate

0.132 (0.045–0.254)

59

  Severe

0.243 (0.126–0.359)

 Headache

60

  Migraine

0.534 (0.426–0.649)

61

  Tension-type

0.109 (0.034–0.227)

62

  Medication overuse

0.205 (0.093–0.33)

 Multiple sclerosis

63

  Mild

0.124 (0.042–0.242)

64

  Moderate

0.315 (0.195–0.418)

65

  Severe

0.689 (0.578–0.81)

 Epilepsy

66

  Severe (seizures >  = once a month)

0.57 (0.467–0.687)

67

  Less severe (seizures 1–11 per year)

0.425 (0.305–0.528)

 Parkinson’s disease

68

  Mild

0.025 (0.002–0.092)

69

  Moderate

0.333 (0.209–0.436)

70

  Severe

0.559 (0.448–0.682)

Mental, behavioural, and substance use disorders

 Alcohol use disorder

71

  Very mild

0.033 (0.004–0.111)

72

  Mild

0.127 (0.045–0.247)

73

  Moderate

0.23 (0.115–0.349)

74

  Severe

0.286 (0.169–0.396)

 Fetal alcohol syndrome

75

  Mild

0.028 (0.003–0.098)

76

  Moderate

0.07 (0.016–0.173)

77

  Severe

0.132 (0.047–0.247)

 Cannabis dependence

78

  Mild

0.279 (0.166–0.386)

79

  Severe

0.474 (0.361–0.585)

 Amphetamine dependence

80

  Mild

0.266 (0.144–0.379)

81

  Severe

0.613 (0.502–0.729)

 Cocaine dependence

82

  Mild

0.24 (0.127–0.355)

83

  Severe

0.534 (0.422–0.652)

 Heroin and other opioid dependence

84

  Mild

0.428 (0.318–0.528)

85

  Severe

0.699 (0.579–0.827)

 Anxiety disorders

86

  Mild

0.024 (0.002–0.091)

87

  Moderate

0.113 (0.035–0.233)

88

  Severe

0.49 (0.375–0.603)

 Major depressive disorder

89

  Mild episode

0.067 (0.015–0.171)

90

  Moderate episode

0.509 (0.404–0.617)

91

  Severe episode

0.607 (0.497–0.731)

 Bipolar disorder

92

  Manic episode

0.506 (0.398–0.616)

93

  Residual state

0.035 (0.005–0.109)

 Schizophrenia

94

  Acute state

0.69 (0.583–0.818)

95

  Residual state

0.458 (0.341–0.569)

96

  Anorexia nervosa

0.072 (0.017–0.176)

97

  Bulimia nervosa

0.048 (0.008–0.139)

98

  Attention deficit hyperactivity disorder

0.019 (0.002–0.074)

99

  Conduct disorder

0.196 (0.09–0.315)

100

  Borderline intellectual functioning

0.015 (0.001–0.063)

 Intellectual disability/mental retardation

101

  Mild

0.056 (0.011–0.157)

102

  Moderate

0.084 (0.022–0.195)

103

  Severe

0.085 (0.023–0.196)

104

  Profound

0.189 (0.085–0.307)

Hearing and vision loss

 Hearing loss

105

  Mild

0.021 (0.002–0.079)

106

  Moderate

0.053 (0.009–0.147)

107

  Severe

0.219 (0.108–0.338)

108

  Profound

0.205 (0.096–0.329)

109

  Complete

0.164 (0.066–0.279)

110

  Mild, with ringing

0.032 (0.004–0.107)

111

  Moderate, with ringing

0.058 (0.011–0.153)

112

  Severe, with ringing

0.29 (0.172–0.402)

113

  Profound, with ringing

0.201 (0.096–0.32)

114

  Complete, with ringing

0.298 (0.173–0.408)

 Distance vision

115

  Mild impairment

0.008 (0–0.041)

116

  Moderate impairment

0.023 (0.002–0.087)

117

  Severe impairment

0.232 (0.123–0.346)

118

  Blindness

0.194 (0.087–0.313)

119

  Monocular

0.032 (0.004–0.106)

120

  Presbyopia

0.009 (0–0.045)

Musculoskeletal disorders

 Low back pain

121

  Mild

0.026 (0.003–0.093)

122

  Moderate

0.081 (0.021–0.192)

123

  Severe, without leg pain

0.141 (0.053–0.258)

124

  Severe, with leg pain

0.151 (0.059–0.269)

125

  Most severe, without leg pain

0.197 (0.089–0.313)

126

  Most severe, with leg pain

0.207 (0.099–0.326)

 Neck pain

127

  Mild

0.024 (0.003–0.089)

128

  Moderate

0.064 (0.013–0.162)

129

  Severe

0.133 (0.047–0.254)

130

  Most severe

0.119 (0.039–0.235)

 Musculoskeletal problems

131

  Legs, mild

0.031 (0.004–0.102)

132

  Legs, moderate

0.111 (0.035–0.226)

133

  Legs, severe

0.147 (0.057–0.269)

134

  Arms, mild

0.025 (0.002–0.088)

135

  Arms, moderate

0.088 (0.023–0.196)

136

  Generalized, moderate

0.147 (0.054–0.264)

137

  Generalized, severe

0.335 (0.214–0.436)

138

  Gout, acute

0.184 (0.08–0.305)

 Injury

139

  Amputation of one upper limb (long term, without treatment)

0.133 (0.05–0.255)

140

  Concussion (short term)

0.048 (0.008–0.138)

141

  Spinal cord lesion, below neck level (treated)

0.399 (0.27–0.501)

Other

 Abdominopelvic problem

142

  Mild

0.03 (0.003–0.107)

143

  Moderate

0.105 (0.033–0.221)

144

  Severe

0.334 (0.222–0.432)

 Anaemia

145

  Mild

0.005 (0–0.027)

146

  Moderate

0.053 (0.01–0.145)

147

  Severe

0.146 (0.057–0.266)

148

  Periodontitis

0.008 (0–0.038)

149

  Dental caries: symptomatic

0.009 (0–0.044)

150

  Severe tooth loss

0.031 (0.004–0.103)

 Disfigurement

151

  Level 1

0.034 (0.005–0.114)

152

  Level 2

0.131 (0.046–0.251)

153

  Level 3

0.628 (0.52–0.751)

154

  Level 1, with itch or pain

0.053 (0.01–0.142)

155

  Level 2, with itch or pain

0.192 (0.086–0.313)

156

  Level 3, with itch or pain

0.641 (0.536–0.763)

 Generic uncomplicated disease

157

  Worry and daily medication

0.022 (0.002–0.082)

158

  Anxiety about diagnosis

0.007 (0–0.035)

159

  Kwashiorkor

0.05 (0.009–0.146)

160

  Severe wasting

0.079 (0.018–0.186)

161

  Speech problems

0.021 (0.002–0.077)

 Motor impairment

162

  Mild

0.016 (0.001–0.07)

163

  Moderate

0.041 (0.007–0.124)

164

  Severe

0.168 (0.068–0.295)

 Motor plus cognitive impairments

165

  Mild

0.041 (0.006–0.128)

166

  Moderate

0.07 (0.014–0.179)

167

Severe

0.252 (0.139–0.359)

168

  Rectovaginal fistula

0.432 (0.311–0.539)

169

  Vesicovaginal fistula

0.211 (0.102–0.323)

170

  Thrombocytopenic purpura

0.09 (0.024–0.203)

171

  Hypothyroidism

0.012 (0.001–0.054)

172

  Hyperthyroidism

0.05 (0.008–0.138)

173

  Neck pain, moderate

0.078 (0.02–0.188)

174

  Osteomyelitis

0.074 (0.017–0.181)

175

  Shoulder lesions

0.013 (0.001–0.057)

176

  Heart burn & reflux “GERD”

0.062 (0.013–0.174)

177

  Constipation

0.032 (0.004–0.108)

178

  Vaginal discharge

0.009 (0–0.047)

179

  Dyspareunia

0.009 (0–0.045)

180

  Stress incontinence

0.021 (0.002–0.081)

181

  Irritable bowel syndrome

0.038 (0.005–0.118)

182

  Somatoform disorder

0.089 (0.023–0.199)

183

  Borderline personality disorder

0.167 (0.071–0.287)

184

  Harmful alcohol use

0.068 (0.016–0.168)

185

  Vertigo and balance disorder (Menière, labyrinthitis)

0.044 (0.007–0.131)

186

  Trigeminal neuralgia

0.053 (0.009–0.142)

187

  Encephalopathy—moderate

0.142 (0.052–0.259)

188

  Encephalopathy—severe

0.274 (0.155–0.383)

189

  Thrombocytopenic purpura

0.074 (0.018–0.183)

190

  Lymphogranuloma Venereum—local infection

0.053 (0.01–0.144)

191

  Subacute sclerosing panencephalitis—phase 1

0.039 (0.006–0.121)

192

  Subacute sclerosing panencephalitis—phase 2

0.102 (0.029–0.219)

193

  Subacute sclerosing panencephalitis—phase 3

–

194

  Haemorrhoids

0.049 (0.009–0.143)

195

  Anal fissure/abcess/fistula

0.039 (0.005–0.122)

196

  Hyperthyroidism

0.05 (0.008–0.141)

197

  Allergic rhinitis (hay fever)

0.005 (0–0.029)

198

  Varicose veins

0.024 (0.002–0.088)

199

  Carpal tunnel syndrome

0.019 (0.002–0.074)

200

  Intensive care unit admission

0.547 (0.429–0.653)

201

  Invasive device/drain

0.103 (0.031–0.216)

202

  Insomnia

0.019 (0.002–0.076)

203

  Sleep apnoea

0.05 (0.008–0.14)

204

  Hypothyroidism

0.019 (0.002–0.074)

205

  Hearing loss, moderate (modified)

0.069 (0.016–0.176)

206

  Hearing loss, severe (modified)

0.297 (0.177–0.403)